scPharmaceuticals Inc (SCPH)
4.77
+0.10
(+2.14%)
USD |
NASDAQ |
May 03, 10:50
scPharmaceuticals Accounts Receivable (Quarterly): 4.489M for Dec. 31, 2023
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 4.489M |
September 30, 2023 | 4.175M |
June 30, 2023 | 1.61M |
Date | Value |
---|---|
March 31, 2023 | 3.004M |
December 31, 2022 | 0.00 |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
--
Minimum
Dec 2022
4.489M
Maximum
Dec 2023
2.656M
Average
3.004M
Median
Mar 2023
Accounts Receivable (Quarterly) Benchmarks
Anika Therapeutics Inc | 35.96M |
Spero Therapeutics Inc | -- |
electroCore Inc | 0.717M |
NovaBay Pharmaceuticals Inc | 0.759M |
Palatin Technologies Inc | 2.346M |